Published in Transfusion on December 03, 2010
Red blood cell alloimmunisation after platelet transfusion: a 5-year study. Blood Transfus (2013) 1.09
Platelet transfusion - the art and science of compromise. Transfus Med Hemother (2013) 0.94
Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility. Asian J Transfus Sci (2015) 0.78
Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br J Haematol (2014) 0.77
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors? Transfusion (2011) 0.76
Delayed Serological Transfusion Reaction After Platelet Transfusion Due to Anti-e. Indian J Hematol Blood Transfus (2016) 0.75
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood (2008) 7.73
[Prothrombin index prolongation due to N-acetylcysteine during the treatment of Amanita phalloides poisoning]. Med Clin (Barc) (2008) 2.04
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood (2010) 1.86
Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion (2005) 1.82
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites. Hepatology (2005) 1.53
Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Blood (2009) 1.51
Factors affecting red blood cell storage age at the time of transfusion. Transfusion (2013) 1.47
Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support. Am J Hematol (2011) 1.46
The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA. Transfusion (2002) 1.44
Cocaine-induced acute hepatitis and thrombotic microangiopathy. JAMA (2005) 1.39
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis (2005) 1.32
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. Blood (2010) 1.29
Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation. Transplantation (2010) 1.20
Improving survival trends in primary myelofibrosis: an international study. J Clin Oncol (2012) 1.19
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion (2012) 1.13
Viscoelastic test and fibrinogen values: how much disagreement is permissible? Anesth Analg (2014) 1.10
Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia (2010) 1.06
Second Language Acquisition of Gender Agreement in Explicit and Implicit Training Conditions: An Event-Related Potential Study. Lang Learn (2010) 1.05
Explicit and implicit second language training differentially affect the achievement of native-like brain activation patterns. J Cogn Neurosci (2011) 1.00
Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica (2002) 0.98
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transplant (2010) 0.98
Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment. Br J Haematol (2011) 0.98
Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells. FEBS Lett (2006) 0.93
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Anticancer Drugs (2007) 0.90
The epidemiology of blood component transfusion in Catalonia, Northeastern Spain. Transfusion (2011) 0.90
Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. Nephrol Dial Transplant (2003) 0.89
Erythropoietin triggers a signaling pathway in endothelial cells and increases the thrombogenicity of their extracellular matrices in vitro. Thromb Haemost (2002) 0.89
Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer (2006) 0.89
Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmun Rev (2011) 0.89
Massive intravascular haemolysis during Clostridium perfrigens sepsis of hepatic origin. Eur J Haematol (2009) 0.88
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group. Haematologica (2010) 0.88
Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.88
Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature. Transfus Med Rev (2013) 0.87
An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion (2012) 0.87
Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance. Genes Chromosomes Cancer (2013) 0.85
The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Haematologica (2014) 0.85
Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion (2006) 0.85
[Guide for transfusion of blood components]. Med Clin (Barc) (2005) 0.85
Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion (2010) 0.85
Gene-gene interaction between interleukin-1A and interleukin-8 increases Alzheimer's disease risk. J Neurol (2004) 0.85
MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia. Leuk Lymphoma (2013) 0.85
Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma. Transfusion (2004) 0.85
Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biol Blood Marrow Transplant (2013) 0.84
Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology (Berl) (2011) 0.84
Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion (2003) 0.84
Advances in the understanding and management of primary myelofibrosis. Curr Opin Oncol (2011) 0.84
Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum. Am J Kidney Dis (2008) 0.83
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Blood (2012) 0.83
G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditions. Exp Hematol (2004) 0.83
Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus (2012) 0.83
Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica (2004) 0.83
Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature. Medicine (Baltimore) (2014) 0.83
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol (2008) 0.82
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia. Ann Hematol (2015) 0.82
Prognostication in primary myelofibrosis. Curr Hematol Malig Rep (2012) 0.81
Platelet dose for prophylactic platelet transfusions. Expert Rev Hematol (2010) 0.81
Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med (2011) 0.81
Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets (2014) 0.81
Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Psychoneuroendocrinology (2009) 0.81
Transfusion medicine illustrated. Erythrophagocytosis in cold agglutinin disease. Transfusion (2010) 0.81
Do patient-related blood donors represent a threat to the safety of the blood supply? Haematologica (2002) 0.81
Haptoglobin is present in albumin used as a replacement solution for plasma exchange. Transfusion (2012) 0.80
Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol (2003) 0.80
Physical stability of liposomes bearing hemostatic activity. Chem Phys Lipids (2003) 0.80
Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction. Microvasc Res (2011) 0.80
Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model. J Hepatol (2003) 0.80
Nitro-oxidative stress after neuronal ischemia induces protein nitrotyrosination and cell death. Oxid Med Cell Longev (2013) 0.80
Native-like brain processing of syntax can be attained by university foreign language learners. Neuropsychologia (2013) 0.79
Biocompatibility of cellulosic and synthetic membranes assessed by leukocyte activation. Am J Nephrol (2004) 0.79
Hepatitis E. Vox Sang (2015) 0.79
Nuclear factor k B is activated in myelodysplastic bone marrow cells. Haematologica (2002) 0.79
Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression. Hum Psychopharmacol (2002) 0.78
Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Transfusion (2007) 0.78
Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials. Transfusion (2007) 0.78
Hormonal response to buspirone is not impaired in major depression. Hum Psychopharmacol (2007) 0.78
Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin. Am J Pathol (2002) 0.78
Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia. Semin Hematol (2004) 0.78
Guidelines on haemovigilance of post-transfusional iron overload. Blood Transfus (2012) 0.78
Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model. Transfusion (2004) 0.77
Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression. Hum Psychopharmacol (2004) 0.77
Verbal Inflectional Morphology in L1 and L2 Spanish: A Frequency Effects Study Examining Storage versus Composition. Lang Learn (2010) 0.77
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter (2004) 0.77
TRAP induces more intense tyrosine phosphorylation than thrombin with differential ultrastructural features. Am J Pathol (2002) 0.77
Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br J Haematol (2014) 0.77
Atomic force microscopy of liposomes bearing fibrinogen. Bioconjug Chem (2003) 0.77